Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis.

CMKLR1 ChemR23 chemerin chemical carcinogenesis squamous cell carcinoma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2019
Historique:
received: 18 07 2019
accepted: 30 10 2019
entrez: 6 12 2019
pubmed: 6 12 2019
medline: 6 12 2019
Statut: epublish

Résumé

Chemerin is a multifunctional protein acting mainly through the G protein-coupled receptor ChemR23/CMKLR1/Chemerin

Identifiants

pubmed: 31803622
doi: 10.3389/fonc.2019.01253
pmc: PMC6873210
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1253

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 Dubois-Vedrenne, De Henau, Robert, Langa, Al Delbany, Vosters, Angelats-Canals, Vernimmen, Luangsay, Wittamer and Parmentier.

Références

Front Immunol. 2018 Nov 30;9:2772
pubmed: 30555465
J Immunol. 2009 Nov 15;183(10):6489-99
pubmed: 19841182
J Immunol. 2011 Aug 1;187(3):1403-10
pubmed: 21715684
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
PLoS Pathog. 2011 Nov;7(11):e1002358
pubmed: 22072972
Oncogene. 2017 Jun 22;36(25):3541-3552
pubmed: 28114280
J Biol Chem. 2011 Nov 11;286(45):39510-9
pubmed: 21949124
J Immunol. 2005 Jul 1;175(1):487-93
pubmed: 15972683
Tumour Biol. 2016 May;37(5):6337-42
pubmed: 26628300
Mutat Res. 2008 Jul-Aug;659(1-2):15-30
pubmed: 18485806
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):331-8
pubmed: 22119008
J Invest Dermatol. 1997 Jul;109(1):91-5
pubmed: 9204961
Peptides. 2014 Jan;51:131-8
pubmed: 24274970
J Immunol. 2012 Jul 15;189(2):956-67
pubmed: 22696441
Mol Cell Endocrinol. 2015 Dec 5;417:36-51
pubmed: 26363224
Oncotarget. 2019 Jan 4;10(2):98-112
pubmed: 30719206
PLoS One. 2016 Oct 7;11(10):e0164179
pubmed: 27716822
PLoS One. 2018 Aug 30;13(8):e0202780
pubmed: 30161155
Semin Cancer Biol. 2005 Dec;15(6):460-73
pubmed: 16039870
Eur J Immunol. 1998 May;28(5):1689-700
pubmed: 9603476
J Biol Chem. 2007 Sep 21;282(38):28175-88
pubmed: 17635925
J Exp Med. 2003 Oct 6;198(7):977-85
pubmed: 14530373
Eur J Endocrinol. 2009 Aug;161(2):339-44
pubmed: 19497986
Hum Reprod. 2012 Jun;27(6):1790-800
pubmed: 22447628
Dermatol Surg. 2000 Jun;26(6):521-30
pubmed: 10848931
J Exp Med. 2009 Jan 16;206(1):249-58
pubmed: 19114666
J Exp Med. 2008 Sep 29;205(10):2207-20
pubmed: 18794339
Front Immunol. 2016 Jun 10;7:224
pubmed: 27375622
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):64-9
pubmed: 18165312
J Exp Med. 2005 Feb 21;201(4):509-15
pubmed: 15728234
J Immunol. 2009 Nov 15;183(10):6717-23
pubmed: 19864606
Eur J Dermatol. 2008 Nov-Dec;18(6):638-41
pubmed: 18955196
J Exp Med. 2012 Jul 30;209(8):1427-35
pubmed: 22753924
Physiol Rep. 2018 Dec;6(24):e13962
pubmed: 30588761
Pharmacol Rev. 2018 Jan;70(1):174-196
pubmed: 29279348
Endocrinology. 2007 Oct;148(10):4687-94
pubmed: 17640997
Nat Protoc. 2009;4(9):1350-62
pubmed: 19713956
Blood. 2007 May 1;109(9):3625-32
pubmed: 17202316
J Clin Endocrinol Metab. 2010 May;95(5):2476-85
pubmed: 20237162
Immunology. 2019 Jul;157(3):248-256
pubmed: 31063220
J Biol Chem. 2005 Oct 14;280(41):34661-6
pubmed: 16096270
Genomics. 1994 Oct;23(3):609-18
pubmed: 7851889
Blood. 2010 Oct 21;116(16):2942-9
pubmed: 20606167
J Immunol. 2016 Feb 15;196(4):1882-90
pubmed: 26773141
J Invest Dermatol. 2000 Nov;115(5):788-94
pubmed: 11069615
Diabetes. 2009 Dec;58(12):2731-40
pubmed: 19720798
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
J Biol Chem. 2004 Mar 12;279(11):9956-62
pubmed: 14701797
Blood. 2001 Dec 15;98(13):3562-8
pubmed: 11739157
PLoS One. 2015 Feb 06;10(2):e0117830
pubmed: 25659101
J Immunol. 2010 Sep 15;185(6):3728-39
pubmed: 20720202
J Immunol. 2005 Jan 1;174(1):244-51
pubmed: 15611246
Biochem Biophys Res Commun. 2010 Jan 22;391(4):1762-8
pubmed: 20044979
Cancers (Basel). 2010;2(2):436-82
pubmed: 21297902
J Immunol. 2011 May 1;186(9):5457-67
pubmed: 21430224
Clin Lab. 2011;57(11-12):879-85
pubmed: 22239017

Auteurs

Ingrid Dubois-Vedrenne (I)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Olivier De Henau (O)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Virginie Robert (V)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Francina Langa (F)

Centre d'Ingénierie Génétique Murine (CIGM), Institut Pasteur, Paris, France.

Joaquim Javary (J)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Diana Al Delbany (D)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Olivier Vosters (O)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Edgar Angelats-Canals (E)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Maxime Vernimmen (M)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Souphalone Luangsay (S)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.
Ogeda S.A., Gosselies, Belgium.

Valérie Wittamer (V)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Marc Parmentier (M)

IRIBHM and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Classifications MeSH